Scancell founder says the company is ready to commercialise novel medicines to counteract cancer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAmedeo Resources Regulatory News (AMED)

  • There is currently no data for AMED

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Total Voting Rights

4 Aug 2008 10:03

For immediate release: 4th August 2008

Creon Corporation Plc ("Creon", "Company" or the "Group") TOTAL VOTING RIGHTS

Following the admission on 1 August of 2,005,381 new ordinary shares of 1p each, being the initial consideration for the acquisition of Pinnacle Plus Limited, Creon's issued share capital comprises 12,041,491 ordinary shares of 1p each. All of these shares carry voting rights.

The above figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or change to their interest in, Creon under the FSA's Disclosure and Transparency Rules.

- Ends -

For further information please contact:

Creon Corporation Plc Jonathan Freeman +44 (0)20 7752 0215

Daniel Stewart & Company Plc Oliver Rigby +44 (0)207 776 6550

GTH Media Relations Toby Hall +44 (0)20 7153 8039

Christian Pickel +44 (0)20 7153 8036

vendor
Date   Source Headline
6th Jan 20054:10 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.